GAMT

mass-spec protein — tumor vs normal
Tumor vs Normalmass-specBox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, GAMT mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of GAMT’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where GAMT mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types GAMT is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.

HNSC, COAD, and PDAC are the cancer types where GAMT tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GAMT mass-spec protein (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
HNSCAllII,III,IV−1.135<.00111view →
COADMaleAll−0.816<.0019view →
PDACFemaleAll−1.869<.0018view →
CCRCCAllAll−0.298<.0017view →
LSCCAllAll+0.287<.0015view →
LUADFemaleAll+0.152.0292view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

GAMT–HNSC

Tumor-vs-normal mass-spec protein box plot for GAMT in HNSC.

Open the HNSC breakdown →

Exploration